Infectologia

Resistência antibiótica durante e depois da COVID-19.

8 Jul, 2021 | 09:52h

Antibiotic resistance during and beyond COVID-19 – JAC-Antimicrobial Resistance

---

Perspectiva | Pessoas com problemas imunológicos deveriam tomar uma 3ª dose de vacina?

8 Jul, 2021 | 09:51h

Should People With Immune Problems Get Third Vaccine Doses? – The New York Times (poucos artigos gratuitos por mês)

Relacionado: [Preprint] 3rd AstraZeneca shot gives strong immunity. E Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.

 

---

Comentário sobre estudo | Neutropenia febril – Procalcitonina vs. escore MASCC.

8 Jul, 2021 | 09:45h

Febrile Neutropenia – Procalcitonin vs MASCC Score – Journal Feed

Estudo original: Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department – The Journal of Emergency Medicine

---

Comentário sobre estudo | Diminuição no uso de antibióticos para otite média aguda e sinusite aguda após implementação da imunização infantil com vacina pneumocócica conjugada (pneumococcal conjugate vaccine – PCV13).

8 Jul, 2021 | 09:44h

Decreased Antibiotic Use for Acute Otitis Media and Acute Sinusitis Following Implementation of Childhood PCV13 Immunization – NEJM Journal Watch

Estudo original: Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada – Journal of Antimicrobial Chemotherapy

 

---

M-A | As intervenções de gestão de antimicrobianos são efetivas e seguras nas instituições de cuidado de longo prazo?

8 Jul, 2021 | 09:43h

Are antimicrobial stewardship interventions effective and safe in long-term care facilities? A systematic review and meta-analysis – Clinical Microbiology and Infection

---

Diretriz da OMS sobre drogas para Covid-19 – Bloqueadores do receptor da interleucina-6 agora são recomendados para pacientes com Covid-19 grave ou crítica.

7 Jul, 2021 | 08:14h

A living WHO guideline on drugs for covid-19 – The BMJ

 

Comentário no Twitter

The latest version of this @WHO living guidance provides a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19. Read the updated WHO guideline on drugs for #COVID19 https://t.co/FUb9yzFRwo

— The BMJ (@bmj_latest) July 6, 2021

 

---

M-A | Associação entre administração de antagonistas de IL-6 e mortalidade entre pacientes hospitalizados com COVID-19 – “A redução absoluta de 4% no risco de mortalidade (de 25% para 21%) com inibidores de IL-6 somados a glicocorticoides pode não se refletir em pacientes com risco basal de mortalidade mais baixo, e parece não justificar o custo adicional e o risco de toxicidade para pacientes hospitalizados com pouca necessidade de oxigênio e curso clínico estável (do editorial).”

7 Jul, 2021 | 08:12h

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis – JAMA

Editorial: IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How? – JAMA

Comentários: Interleukin-6 antagonists improve outcomes in hospitalised COVID-19 patients – King’s College London E WHO advises 2 monoclonal antibodies for severe COVID – CIDRAP

 

Comentário no Twitter (fio – clique para saber mais)

1/n
Here we go –
Our paper assessing the role of interleukin-6 antagonists treatments in the management of COVID-19 patients?https://t.co/AJErHypx9a@WHO @jonathanasterne @diazjv @JAMA_current @KCLImmunoMicro @GSTT_ICU @GSTTresearch

— Manu Shankar-Hari (@msh_manu) July 6, 2021

 

---

OMS recomenda bloqueadores do receptor de interleucina-6 para salvar vidas na COVID-19 e pressiona os produtores a unir forças para aumentar rapidamente o acesso – “Estes são os primeiros medicamentos que se demonstraram efetivos contra a COVID-19 desde que os corticosteroides foram recomendados pela OMS em setembro de 2020.”

7 Jul, 2021 | 08:11h

WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

🆕 treatment recommendation from WHO:
WHO recommends life-saving interleukin-6 receptor blockers to treat #COVID19 and urges producers to join efforts to rapidly increase access.

👉https://t.co/h4IcZad2VA pic.twitter.com/YXPkuBVwY4

— World Health Organization (WHO) (@WHO) July 6, 2021

 

---

Usar máscara se você já está vacinado? Por que a OMS e o CDC não recomendam a mesma orientação.

7 Jul, 2021 | 08:10h

Wear a mask if you’re vaccinated? Why the WHO and CDC don’t have the same guidance – C|Net

Relacionado: WHO urges fully vaccinated people to continue to wear masks as delta Covid variant spreads. E What the science says about lifting mask mandates – “Wearing masks should probably be one of the last things we stop doing”. E CDC says fully vaccinated Americans can go indoors and outdoors without masks.

---

Diretriz RCOG | Vacinação contra o coronavírus (COVID-19) na gestação.

7 Jul, 2021 | 08:08h

Coronavirus (COVID-19) Vaccination in Pregnancy – Royal College of Obstetricians & Gynaecologists

Ver também: Resources and FAQs – Royal College of Obstetricians & Gynaecologists

 

Comentário no Twitter

We have published an interim update to the main coronavirus and pregnancy guidance to summarise the guidance on COVID-19 vaccination and pregnancy. Find out more: https://t.co/2YDyZFrVWJ pic.twitter.com/KnwXDvZls2

— RoyalCollegeObsGyn (@RCObsGyn) July 1, 2021

 

---